Yuesong Pan Selected Research

Albumins

4/2024	Inflammation and Adverse Outcomes in Patients With Acute Ischemic Stroke With and Without Chronic Kidney Disease.
1/2024	Low HALP (Hemoglobin, Albumin, Lymphocyte, and Platelet) Score Increases the Risk of Post-Stroke Cognitive Impairment: A Multicenter Cohort Study.
12/2023	Association between Urine Albumin-to-creatinine Ratio and Intracranial Atherosclerotic Plaque in Chinese Adults - Results from the PRECISE Study.
11/2023	Association between Fibrinogen-to-Albumin Ratio and Adverse Stroke Outcomes among Patients with Acute Ischemic Stroke.
7/2023	The Association Between the Fibrinogen-to-Albumin Ratio and Intracranial Arterial Stenosis in Patients With Acute Ischemic Stroke.
6/2023	Smokers with Elevated Glycated Albumin Could Not Benefit from Dual Antiplatelet Therapy After Minor Stroke or Transient Ischemic Attack.
1/2022	The Association between Baseline and 3-Month Albuminuria and 1-Year Prognosis of Ischemic Stroke.
1/2022	Association of Urine Albumin-Creatinine Ratio and Cystatin C-Based Estimated GFR with Outcomes in Patients with Ischemic Stroke.
1/2021	Serum calcium and long-term outcome after ischemic stroke: Results from the China National stroke registry III.
11/2017	Stress Hyperglycemia and Prognosis of Minor Ischemic Stroke and Transient Ischemic Attack: The CHANCE Study (Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuesong Pan Research Topics

Disease

137	Stroke (Strokes) 05/2024 - 01/2013
126	Ischemic Stroke 06/2024 - 01/2014
50	Transient Ischemic Attack 01/2024 - 06/2014
22	Hemorrhage 05/2024 - 07/2015
15	Insulin Resistance 02/2024 - 01/2017
14	Diabetes Mellitus 01/2023 - 08/2013
13	Pathologic Constriction (Stenosis) 12/2023 - 01/2013
11	Infarction (Infarctions) 06/2024 - 01/2018
9	Atherosclerosis 12/2023 - 08/2018
9	Atrial Fibrillation 03/2023 - 05/2013
9	Prediabetic State (Prediabetes) 01/2023 - 09/2014
8	Cognitive Dysfunction 01/2024 - 01/2019
8	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 01/2017
6	Inflammation (Inflammations) 04/2024 - 01/2019
6	Hyperglycemia 01/2023 - 11/2017
5	Hypertension (High Blood Pressure) 03/2024 - 01/2019
5	Atherosclerotic Plaque (Atheroma) 12/2023 - 10/2022
5	Intracranial Hemorrhages (Intracranial Hemorrhage) 04/2023 - 03/2015
5	Cerebral Small Vessel Diseases 11/2022 - 01/2014
5	Chronic Renal Insufficiency 01/2022 - 01/2018
5	Cerebral Hemorrhage 01/2019 - 10/2015
4	Brain Ischemia (Cerebral Ischemia) 01/2024 - 08/2013
4	Coronary Artery Disease (Coronary Atherosclerosis) 10/2023 - 01/2022
4	Type 2 Diabetes Mellitus (MODY) 11/2020 - 01/2018
3	Thrombosis (Thrombus) 07/2023 - 04/2019
3	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 07/2023 - 06/2016
3	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 12/2019
2	Hemorrhagic Stroke 05/2024 - 01/2018
2	Reperfusion Injury 01/2024 - 02/2019
2	Cerebral Infarction 04/2023 - 01/2021
2	Coronary Disease (Coronary Heart Disease) 01/2023 - 01/2022
2	Pain (Aches) 01/2021 - 01/2018
2	Myocardial Infarction 05/2020 - 04/2019
2	Hematoma 07/2018 - 11/2013
2	Deglutition Disorders (Dysphagia) 01/2017 - 05/2013
2	Heart Failure 02/2016 - 05/2013
2	Leukoaraiosis 11/2014 - 01/2014
1	Sarcopenia 04/2024
1	Malnutrition (Nutritional Deficiencies) 04/2024
1	Carotid Artery Diseases 12/2023

Drug/Important Bio-Agent (IBA)

38	Clopidogrel (Plavix)FDA Link 05/2024 - 06/2014
32	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2024 - 06/2014
31	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 09/2014
17	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2024 - 01/2014
15	Cytochrome P-450 CYP2C19IBA 05/2024 - 07/2016
14	TicagrelorIBA 05/2024 - 01/2017
13	C-Reactive ProteinIBA 09/2023 - 01/2013
10	AlbuminsIBA 04/2024 - 11/2017
9	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2019
8	Hemoglobins (Hemoglobin)IBA 01/2024 - 01/2016
8	Indicators and Reagents (Reagents)IBA 01/2024 - 01/2014
8	Triglycerides (Triacylglycerol)IBA 01/2023 - 11/2015
7	Cystatin CIBA 04/2024 - 01/2021
7	Insulin (Novolin)FDA Link 12/2023 - 01/2018
7	danaparoid (Orgaran)FDA Link 01/2023 - 01/2016
7	Blood Glucose (Blood Sugar)IBA 01/2020 - 05/2013
6	CholesterolIBA 03/2024 - 12/2020
6	oxidized low density lipoproteinIBA 07/2023 - 01/2021
6	LDL CholesterolIBA 07/2023 - 01/2021
5	CreatinineIBA 04/2024 - 01/2022
5	Tenecteplase FDA Link 01/2024 - 01/2022
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 11/2014
4	HDL CholesterolIBA 03/2024 - 12/2021
4	LipidsIBA 01/2023 - 01/2019
3	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 05/2024 - 01/2021
3	Fibrinogen (Factor I)FDA Link 04/2024 - 07/2023
3	Nonesterified Fatty Acids (NEFA)IBA 12/2023 - 01/2020
3	Antihypertensive Agents (Antihypertensives)IBA 10/2023 - 01/2021
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 05/2023 - 01/2019
3	Uric Acid (Urate)IBA 10/2022 - 02/2017
3	Lipoprotein(a)IBA 07/2022 - 12/2019
3	Interleukin-6 (Interleukin 6)IBA 06/2022 - 01/2021
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2020 - 09/2014
2	MelatoninIBA 01/2024 - 02/2019
2	Therapeutic UsesIBA 01/2024 - 02/2019
2	Phenobarbital (Luminal)FDA Link 12/2023 - 01/2020
2	Apolipoproteins B (ApoB)IBA 07/2023 - 12/2022
2	ApolipoproteinsIBA 07/2023 - 12/2022
2	Tirofiban (Aggrastat)FDA Link 05/2023 - 01/2021
2	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2023 - 06/2022
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2023 - 12/2020
2	indobufenIBA 01/2023 - 10/2022
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 06/2022 - 02/2020
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 06/2022 - 02/2020
2	HomocysteineIBA 12/2021 - 07/2018
2	AnticoagulantsIBA 01/2021 - 01/2019
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2024
1	pumiceIBA 01/2024
1	AutoantigensIBA 09/2023
1	muskIBA 09/2023
1	AutoantibodiesIBA 09/2023

Therapy/Procedure

50	Therapeutics 06/2024 - 01/2013
15	Secondary Prevention 01/2023 - 06/2017
13	Thrombectomy 05/2024 - 06/2016
5	Stents 05/2020 - 08/2018
3	Length of Stay 01/2017 - 03/2014
2	Punctures 01/2021 - 01/2021
2	Glycemic Control 01/2019 - 01/2018
1	Decompressive Craniectomy 02/2024
1	Time-to-Treatment 01/2024